,
Cabinet Health

Reinventing America's Medicine Cabinet

About this Event

Cabinet Health is on a mission to eliminate the 190 billion single use plastic medicine bottles while improving product quality and creating a personalized experience for its customers.

Cabinet’s proprietary compostable packaging is FDA approved, patented, and can be used with more than 25 OTC medicines and over 200 prescriptions. But Cabinet is more than just a packaging company. They are leveraging multigenerational experience in the pharmaceutical industry to source and manufacture high quality medicines that go in the packaging. Unlike other drug manufacturers, Cabinet goes beyond FDA standards and independently tests every batch of medicine to ensure it is free of carcinogens, toxins, heavy metals and allergens.

Cabinet OTC products are currently sold by Amazon, Target, CVS, and Grove, as well as through their online portal. Their online prescription business is growing quickly and currently has a waitlist of 23,000 patients.

Watch the webinar with co-founder and CEO, Achal Patel, to learn how Cabinet Health is poised to disrupt the $61B sustainable OTC and Rx market.

Video On Demand

SHARE THIS EVENT

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.